logo
Microbot Medical® Expands Commercial Leadership with Appointment of Christina Bailey as VP of Sales

Microbot Medical® Expands Commercial Leadership with Appointment of Christina Bailey as VP of Sales

Yahoo4 days ago
Company Continues to Strengthen Organizational Infrastructure with Success-Driven Medical Device Veteran
Christina Bailey, VP of Sales, Microbot Medical
HINGHAM, Mass., July 22, 2025 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer of the innovative LIBERTY® Endovascular Robotic System, announced the appointment of Christina Bailey as its new Vice President of Sales. A two-time U.S. Olympian with 20 years of medical device sales experience, Ms. Bailey has successfully led commercial teams to achieve sales goals. She will report directly to Harel Gadot, the Company's CEO, President and Chairman.
Ms. Bailey has held a variety of sales leadership roles. She has worked with notable companies like Boston Scientific, Abbott, Stryker and Intuitive Surgical that have equipped her with the insights necessary to drive growth and innovation. As the Vice President of US Sales at Endologix, her leadership in building and scaling the sales team while achieving sales milestones demonstrate her capability to lead crucial product launches. Ms. Bailey serves as a Board Member for USA Hockey. As a member of the U.S.A. Women's Hockey Team, she won a gold medal at the 1998 Winter Olympics held in Nagano, Japan.
'Christina is a sales leader with a track record of building and working within high-performing teams across her professional and Olympic careers,' commented Mr. Gadot. 'We believe her leadership will strengthen our commercial efforts as she begins establishing an experienced and mission-driven sales team to support our anticipated launch of LIBERTY.'
LIBERTY is an investigational device pending FDA 510(k) clearance, and is currently not available for sale in the U.S.
About Microbot Medical
Microbot Medical Inc. (NASDAQ: MBOT) is a pre-commercial stage medical technology company with a vision to redefine endovascular robotics and improve the quality of care for millions of patients and providers globally. The Company has developed the world's first single-use, fully disposable endovascular robotic system, which aims to eliminate traditional barriers to accessing advanced robotic systems.
Further information about Microbot Medical® is available at http://www.microbotmedical.com.
Safe Harbor
Statements to future financial and/or operating results, future growth in research, technology, clinical development, commercialization and potential opportunities for Microbot Medical Inc. and its subsidiaries, along with other statements about the future expectations, beliefs, goals, plans, or prospects expressed by management, constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and the Federal securities laws. Any statements that are not historical fact (including, but not limited to statements that contain words such as 'contemplates,' 'continues,' 'could,' 'forecasts,' 'intends,' 'may,' 'might,' 'possible,' 'potential,' 'predicts,' 'projects,' 'should,' 'would,' 'will,' 'believes,' 'plans,' 'anticipates,' 'expects,' 'estimates' and similar expressions) should also be considered to be forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. Forward-looking statements involve risks and uncertainties, including, without limitation, the Company's need for and ability to obtain additional working capital to continue its transition to a commercially focused company, market conditions, risks inherent in the development and/or commercialization of the LIBERTY Endovascular Robotic System, uncertainty in the results of regulatory pathways and regulatory approvals, including whether the FDA will timely grant 510(k) clearance to commercially market the LIBERTY Endovascular Robotic System in the United States if at all, uncertainty resulting from political, social and geopolitical conditions, particularly any changes in personnel or processes or procedures at the FDA and announcements of tariffs on imports into the U.S., disruptions resulting from new and ongoing hostilities between Israel and the Palestinians, Iran and other neighboring countries, and maintenance of intellectual property rights. Additional information on risks facing Microbot Medical® can be found under the heading 'Risk Factors' in Microbot Medical's periodic reports filed with the Securities and Exchange Commission (SEC), which are available on the SEC's web site at www.sec.gov. Microbot Medical® disclaims any intent or obligation to update these forward-looking statements, except as required by law.
Investor Contact: IR@microbotmedical.com
A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/efa7e0c8-987b-4e57-8a97-2fcee0a31aa5Sign in to access your portfolio
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Media Mister Marks 13 Years of Supporting Creators in the Digital Age
Media Mister Marks 13 Years of Supporting Creators in the Digital Age

Yahoo

time3 minutes ago

  • Yahoo

Media Mister Marks 13 Years of Supporting Creators in the Digital Age

As Media Mister celebrates its 13th anniversary on July 11, 2025, the company reflects on more than a decade of supporting creators, adapting to platform shifts, and building digital trust worldwide. NEW YORK, July 26, 2025 (GLOBE NEWSWIRE) -- Earlier this month, Media Mister marked a major milestone—13 years since its founding on July 11, 2012. This anniversary celebrates over a decade of continuous evolution in support of creators, marketers, and businesses navigating an ever-changing digital landscape. Launched during the early wave of Facebook and YouTube's rise, Media Mister quickly identified the need for solutions that helped individuals build authentic engagement online. What started as a small service in 2012 has grown into a globally recognized platform used by hundreds of thousands across diverse creative industries. 'When we started, the term 'creator economy' didn't even exist,' said , . 'What's remained constant over these 13 years is our belief in helping people and brands be heard—authentically and sustainably—in the fast-moving world of social media.' Milestones from the Journey 2012: Launched on July 11 with a focus on digital engagement services 2015: Expanded to major platforms like Instagram, YouTube, and TikTok 2018: Crossed 100K users and introduced bundled growth solutions 2020: Upgraded backend to strengthen privacy and platform integrity 2023: Went multilingual with support in 5 global languages 2025: Surpassed 500K orders and 270K+ satisfied customers Today, Media Mister supports a global community of creators, entrepreneurs, educators, musicians, and marketers working to build meaningful digital visibility. With a firm commitment to ethical engagement, transparent practices, and user empowerment, the company continues to adapt in step with the digital economy. 'We've witnessed the shift in how creators and communities connect online,' added. 'And we're focused on evolving with them in thoughtful, ethical ways that reflect what they truly need.' As the anniversary approaches, the company's focus is on platform adaptability, multilingual expansion, and smarter tools for the next generation of creators. About Media MisterFounded on July 11, 2012, Media Mister is a global digital service provider that supports creators and brands across platforms like Instagram, YouTube, TikTok, LinkedIn, and more. With over a decade of experience and a customer-first approach, the company continues to shape the evolving landscape of digital presence. Media Contact: John RamptonEmail: pr@ Disclaimer: This press release is provided by the Media Mister. The statements, views, and opinions expressed in this content are solely those of the content provider and do not necessarily reflect the views of this media platform or its publisher. This content is for informational purposes only and should not be considered financial, investment, or trading advice. Readers are strongly encouraged to conduct their own research and consult with a qualified financial advisor before making any investment decisions. Neither the media platform nor the publisher shall be held responsible for any fraudulent activities, misrepresentations, or financial losses arising from the content of this press release. A photo accompanying this announcement is available at in to access your portfolio

A farewell to Ozzy, Coke's sugar high, another vaccine shake-up: The week in review
A farewell to Ozzy, Coke's sugar high, another vaccine shake-up: The week in review

Yahoo

time3 minutes ago

  • Yahoo

A farewell to Ozzy, Coke's sugar high, another vaccine shake-up: The week in review

RFK shakes up vaccines again Health Secretary Robert F. Kennedy Jr. took another step toward overhauling the nation's vaccine policy when he approved the removal of thimerosal, a mercury-based preservative, from all flu vaccines despite widespread agreement in the medical community that the preservative is safe. Kennedy signed off on a recommendation from the Advisory Committee on Immunization Practices, a panel he replaced with his own appointed members in June, to stop distributing vaccines containing thimerosal, which has long been targeted by anti-vaccine groups. An operatic honor for Melania Republican lawmakers are working on a Kennedy Center production of their own: renaming the center's Opera House to the 'First Lady Melania Trump Opera House.' The House Appropriations Committee, whose spending bill funds the iconic performing arts venue in Washington, voted 33-25 for the change. Lawmakers have already agreed to spend $256.7 million on improvements to the center sought by President Donald Trump, who ousted much of the Kennedy Center's board after he took office and appointed himself chairman. He has criticized some of the center's performances and said in one visit that he 'never liked 'Hamilton' very much.' A sweet twist to the Cola wars Cane sugar: It's the real thing. A Coca-Cola made with cane sugar − not high-fructose corn syrup − is coming to the United States this fall, the company announced, just like the Coke you find overseas, including Mexico. (The long-running debate over which tastes better, U.S. Coke or Mexican Coke, has been a fierce one). The news doesn't come as a compete surprise; President Donald Trump had made a case for cane sugar Coke on social media in mid-July − 'You'll see. It's just better!' Also, not to be outdone, Pepsi announced it is launching Pepsi Prebiotic Cola this fall, in Original Cola and Cherry Vanilla, containing 5 grams of cane sugar and 3 grams of prebiotic fiber. Ozzy Osbourne, the 'Prince of Darkness,' is dead The heavy metal world has lost one of its most beloved characters, Ozzy Osbourne, at age 76, only weeks after reuniting with his original band, Black Sabbath, in England for a farewell show. Osbourne, who was infamous for his hard living (and for biting the head off a bat), exploded into stardom in a solo career and later branched into reality TV with MTV's 'The Osbournes' in the early 2000s. In 2020, he revealed he had Parkinson's disease. In a just-announced new memoir, 'Last Rites,' arriving Oct. 7, Osbourne says: 'Look, if it ends tomorrow, I can't complain. I've been all around the world. … I've done good, and I've done bad. But right now, I'm not ready to go anywhere.' Remembering Ozzy Osbourne: Life on the 'Crazy Train': The metal icon through the years All bets for 2026 are on Scottie Scheffler Scottie Scheffler, fresh off a dominating win at the British Open July 20, is at the top of his game, and you can expect he'll be there for awhile. Scheffler, 29, who also captured the PGA Championship in May and now needs only a U.S. Open victory to enter the elite group of golfers who have won the sport's grand slam of all four major championships, is now the odds-on favorite to win every major in 2026, according to BetMGM. Declared the gaming venture's Matt Wall: 'The comparisons with Tiger Woods certainly don't look out of place right now.' − Compiled by Robert Abitbol This article originally appeared on USA TODAY: A farewell to Ozzy, Coke's sugar high, the flu fight: Week in review

What Does It Cost To Charge a Tesla Monthly Compared To Gas for a BMW 3 Series?
What Does It Cost To Charge a Tesla Monthly Compared To Gas for a BMW 3 Series?

Yahoo

time3 minutes ago

  • Yahoo

What Does It Cost To Charge a Tesla Monthly Compared To Gas for a BMW 3 Series?

Electric vehicles promise a lot, including lower emissions, less maintenance and high-end tech. But for everyday drivers, the real question is simpler: How much does it actually cost to run one? Not the sticker price or tax incentives. The monthly cost to keep it moving. Consider the Tesla Model 3 and the gas-powered BMW 3 Series, two well-known sedans with similar performance. One charges up, the other fills up. And when you break down the costs, the gap between them gets surprisingly wide. Check Out: Read Next: Charging a Tesla The Tesla Model 3 rear-wheel drive (RWD) has an EPA-estimated range of 272 miles and a usable battery capacity of 57.5 kilowatt hours (kWh), according to Green Cars Compare. This translates to an efficiency of about 4.61 miles per kWh under ideal conditions. Assuming an average monthly driving distance of 1,200 miles, the Tesla would use roughly 260 kWh of electricity each month. At the current U.S. average residential electricity rate of 17.45 cents per kWh, according to Choose Energy, monthly charging costs come to about $45.37. Using Tesla Superchargers or other public fast chargers, which typically cost between 40 and 60 cents per kWh, will raise the monthly cost accordingly if relied upon frequently. Discover More: How Long Does Charging Take? Charging time depends on how and where it's done, according to the Department of Transportation. Level 1 (120V outlet): Two to five miles of range per hour. A full charge could take 40 to 50 hours — only useful for very light driving. Level 2 (240V home charger): 10 to 20 miles per hour. Fully recharges in about 4 to 10 hours. Tesla Supercharger: A charge to 80% typically takes 20 minutes to an hour, and adds 180 to 240 miles. Fuel Cost for a BMW 3 Series A 2025 BMW 330i averages around 31 miles per gallon combined, according to Edmunds. Driving 1,200 miles per month means buying about 38.7 gallons of gas. At $3.16 per gallon, the national average as of July 2025, that works out to $122.41 per month. Charging a Tesla Model 3 RWD at home costs about $45 per month, while fueling a BMW 3 Series averages around $122 per month. That's $77 in monthly savings, or $924 annually, just on energy expenses if you choose the Tesla over the BMW. Cost Per Mile Tesla: Uses about 0.22 kWh per mile, with a cost of $0.1745 per kWh. This comes out to roughly 3.8 cents per mile. BMW 3 Series: With gas prices around $3.16 per gallon and an average fuel economy of 31 miles per gallon, the cost comes to about 10 cents per mile. Other Cost Considerations Electric vehicles like the Tesla avoid many routine maintenance expenses common to gas cars, such as no oil changes, no spark plugs and no emissions tests. Regenerative braking also extends brake life, reducing replacement frequency. BMW owners typically face higher maintenance and repair costs, especially as the vehicle ages, along with fluctuating fuel prices that can spike unexpectedly. In contrast, electricity prices tend to be more stable and predictable. More From GOBankingRates How Much Money Is Needed To Be Considered Middle Class in Your State? This article originally appeared on What Does It Cost To Charge a Tesla Monthly Compared To Gas for a BMW 3 Series? Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store